pristane and resiquimod
pristane has been researched along with resiquimod in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Cascalho, M; Clark, KL; Kahlenberg, JM; Morse, MD | 1 |
Alcantar, TM; Anderson, K; Austin, CD; Bacarro, N; Dunlap, D; Eastham, J; Ghilardi, N; Hackney, J; Heredia, J; Hui, J; Katewa, A; Lafkas, D; Lee, WP; Liang, J; Modrusan, Z; Paler-Martinez, A; Rairdan, XY; Suto, E | 1 |
Other Studies
2 other study(ies) available for pristane and resiquimod
Article | Year |
---|---|
Caspase-1 is required for maintenance of marginal zone B cells in pristane-induced lupus.
Topics: Animals; Antibodies, Antinuclear; B-Lymphocytes; Caspase 1; Cells, Cultured; Disease Models, Animal; Ficoll; Genetic Predisposition to Disease; Imidazoles; Immunization; Immunoglobulin G; Immunoglobulin M; Lupus Erythematosus, Systemic; Mice, Inbred BALB C; Mice, Knockout; Nitrophenols; Ovalbumin; Phenotype; Phenylacetates; Spleen; T-Lymphocytes; Terpenes; Time Factors | 2016 |
The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models.
Topics: Animals; Chemokines; Cytokines; Dendritic Cells; Imidazoles; Interferon-alpha; Lupus Erythematosus, Systemic; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred NZB; Mice, Knockout; Survival Rate; Terpenes; Toll-Like Receptor 7; Toll-Like Receptor 9 | 2021 |